Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics
NCT04091711
·
clinicaltrials.gov ↗
NA
Phase
SUSPENDED
Status
20
Enrollment
INDUSTRY
Sponsor class
Stopped
Awaiting next model of the device
Conditions
Oncology
Adherence, Medication
Side Effect
Interventions
DEVICE:
ReX-C system
Sponsor
Dosentrx Ltd.